Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minoxidil Topical Foam in Men With Androgenetic Alopecia
NCT01319370Phase 2Completed
- Start
- Nov 2010
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in androgenetic alopecia (AGA) comparing vehicle of 5% Minoxidl topical foam with 5% Minoxidil topical foam (2 arms). Primary endpoint: Target area non-vellus hair count in the temple region at 24 weeks. Started Nov 2010; status: completed.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT01319370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01319370.